New Report Highlights Increased Importance of Risk Reduction in Chronic Obstructive Pulmonary Disease (COPD) Management

New Report Highlights Increased Importance of Risk Reduction in Chronic Obstructive Pulmonary Disease (COPD) Management PR Newswire VIENNA, September 2, 2012 VIENNA, September 2, 2012 /PRNewswire/ -- - New Expert Report on COPD Launched at a Press Conference at ERS 2012 - Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria. To view the Multimedia News Release, please click: http://www.multivu.com/mnr/56582-expert-report-on-copd-launch The Report, entitled 'The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,' was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients' Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current [1] [1]disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.